• Nexelis to Acquire ImmunXperts contractpharma
    March 06, 2020
    Nexelis, a portfolio company of Ampersand Capital Partners, and a provider of assay development and advanced laboratory testing has signed a definitive agreement to acquire ImmunXperts.
PharmaSources Customer Service